| CURE^® Speaking Out

NG-350A Evaluated in FORTRESS Trial for Locally Advanced Rectal Cancer

Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial

Development of Nemvaleukin for Platinum-Resistant Ovarian Cancer Halted

FDA Approves Initiation of a New Trial in Recurrent Glioblastoma